Business
The Healing Company Achieves Revenue of $8.9 Million for Fiscal 2023 and Positive Adjusted EBITDA for Chopra and Your Super
The Healing Company Achieves Revenue of $8.9 Million for Fiscal 2023 and Positive Adjusted EBITDA for Chopra and Your Super.
About this update from The Healing Company Inc.
[{"type":"text","content":"\n Chopra achieves three-fold sequential increase in revenue for the fiscal 2023 fourth quarter, and Your Super achieves positive adjusted EBITDA1 in fiscal 2023 for the first time in company historyCollectively, The Healing Company portfolio served nearly half a million people this year, advancing its mission to bring integrated healing to the world NEW YORK, NY, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The Healing Company Inc. (OTC: HLCO) today provided a business update and reported financial results for the fiscal year ended June 30, 2023. The Healing Company posted revenue of $8.9 million for fiscal 2023, and sequential revenue for the fiscal 2023 fourth quarter increased by 5% to $3.3 million compared to the third quarter of fiscal 2023. Operating expenses were reduced by 11% for the fiscal 2023 fourth quarter compared to the third quarter of fiscal 2023, and annualized operating expenses were further reduced by nearly $1.8 million in August 2023. “We are pleased to report that we achieved record revenue and positive adjusted EBITDA1 in each segment, excluding one-time, non-recurring expenses, driven by prudent investment, disciplined growth, and reduced operating expenses,” said Simon Belsham, CEO and Co-Founder of The Healing Company. “These strong financial results in a foundational year reflect our rigorous approach to establish The Healing Company as a leading provider of integrated healing products and experiences, as well as our commitment to achieving long-term, sustainable profitability.” The Healing Company continues to advance its mergers & acquisitions strategy within the wellness, supplement, and nutraceuticals sectors, identifying and acquiring high-impact healing brands, and working to grow them sustainably. Belsham stated, “In less than a year since welcoming leading plant-based superfoods brand Your Super into our portfolio, the business achieved a historic milestone of positive adjusted EBITDA, affirming the strength of our business model. Our recent acquisition of Chopra in March 2023, founded by Time 100’s Most Influential People awardee Dr. Deepak Chopra, is already demonstrating strong performance with a significant threefold revenue increase for the fiscal 2023 fourth quarter compared to the previous quarter.” In addition to its mergers and acquisitions strategy...